WNK kinases, distal tubular ion handling and hypertension

Nephrology Dialysis Transplantation

Volumn 18, Issue 12, 2003, Pages 2463-2467

  Faure, Sebastien ^a   Delaloy, Céline ^b   Leprivey, Valérie ^a   Hadchouel, Juliette ^b   Warnock, David G ^c   Jeunemaitre, Xavier ^b   Achard, Jean Michel ^a,d  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c University of Alabama at Birmingham   (United States)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Familial hyperkalaemic hypertension; WNK kinases

Indexed keywords

PROTEIN SERINE THREONINE KINASE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; WNK PROTEIN;

CLINICAL FEATURE; EDITORIAL; FAMILIAL DISEASE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HYPERCALCIURIA; HYPERKALEMIA; HYPERTENSION; ION TRANSPORT; KIDNEY DISTAL TUBULE; NONHUMAN; PRIORITY JOURNAL; SODIUM TRANSPORT;

HUMANS; HYPERKALEMIA; HYPERTENSION; ION TRANSPORT; KIDNEY TUBULES, DISTAL; PROTEIN-SERINE-THREONINE KINASES;

EID: 0344897193     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg426     Document Type: Editorial

References (19)

1. Paver W, Pauline G. Hypertension and hyperpotassaemia without renal disease in a young male. Med J Aust 1964; 2: 305-306
2. Gordon RD: The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome. Aust NZ J Med 1986; 16: 183-184
3. Schambelan M, Sebastian A, Rector FJ. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int 1981; 19: 716-727
4. Stokes G, Gentle J, Edwards K, Stewart J. Syndrome of idiopathic hyperkalemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level. Med J Aust 1968; 2: 1050-1054
5. Arnold JE, Healy JK. Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med 1969; 47: 461-472
6. Mansfield T, Simon D, Farfel Z et al. Multilocus linkage of familial hyperkalemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 1997; 16: 202-205
7. Disse-Nicodeme S, Achard JM, Desitter I et al. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet 2000; 67: 302-310
8. Disse-Nicodeme S, Desitter I, Fiquet-Kempf B et al. Genetic heterogeneity of familial hyperkalemic hypertension. J Hypertens 2001; 19: 1957-1964
9. Wilson F, Disse-Nicodème S, Choate K et al. Mutations in WNK kinases reveal a novel mechanism of human hypertension. Science 2001; 293: 1107-1112
10. Wilson FH, Kahle KT, Sabath E et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003; 21; 100: 680-684
11. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003; 111: 1039-1045
12. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002; 87: 3248-3254
13. Achard JM, Warnock DG, Disse-Nicodeme S et al. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med 2003; 14: 495-498.
14. Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000; 275: 16795-16801
15. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556
16. Rossier BC. Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension? J Clin Invest 2003; 111: 947-950
17. Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension 1999; 33: 1324-1331
18. Verissimo F, Jordan P. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 2001; 20: 5562-5569
19. Xu BE, Min X, Stippec S, Lee BH, Goldsmith EJ, Cobb MH. Regulation of WNK1 by an autoinhibitory domain and autophosphorylation. J Biol Chem. 2002; 277: 48456-48462